Moneycontrol PRO

business

DRL-GSK generic formulations deal under review: PharmAsia

The DRL-GSK deal was to sell branded generic formulations in emerging markets and was entered into in 2009.

first published: Sep 17, 2014 01:11 pm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347